For the year ending 2025-12-31, LENZ made $19,088K in revenue. -$82,081K in net income. Net profit margin of -430.01%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 19,088 | |||
| Cost of sales | 418 | |||
| Selling, general and administrative | 91,138 | |||
| Research and development | 18,670 | |||
| Total operating expenses | 110,226 | |||
| Loss from operations | -91,138 | |||
| Other (expense) income | -243 | |||
| Interest income | 9,756 | |||
| Total other income, net | 9,513 | |||
| Net loss before income taxes | -81,625 | |||
| Income tax expense | 502 | |||
| Net loss | -82,127 | |||
| Unrealized gain on marketable securities | 46 | |||
| Comprehensive loss | -82,081 | |||
| Basic EPS | -2.85 | |||
| Diluted EPS | -2.85 | |||
| Basic Average Shares | 28,813,164 | |||
| Diluted Average Shares | 28,813,164 | |||
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)